Andrea Paul Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Andrea Paul is Chief Legal Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 1.07 Million shares of ZNTL, which is worth approximately $2.21 Million. The most recent transaction as insider was on Feb 03, 2025, when has been sold 13,230 shares (Common Stock) at a price of $1.71 per share, resulting in proceeds of $22,623. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.07M
613.98% 3M change
613.98% 12M change
Total Value Held $2.21 Million

Andrea Paul Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
SELL
Open market or private sale
$22,623 $1.71 p/Share
13,230 Reduced 1.22%
1,070,784 Common Stock
Feb 03 2025
BUY
Grant, award, or other acquisition
-
934,041 Added 46.28%
1,084,014 Common Stock
Feb 02 2024
SELL
Open market or private sale
$38,197 $11.54 p/Share
3,310 Reduced 2.16%
149,973 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
112,500 Added 42.33%
153,283 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
-
40,783 Added 50.0%
40,783 Common Stock

Also insider at

LOGC
LogicBio Therapeutics, Inc. Healthcare
General Counsel and Secretary
AP

Andrea Paul

Chief Legal Officer
New York, NY

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL